Mypher Pharmaceuticals LLP
About Mypher Pharmaceuticals LLP
Data last updated:
Mypher Pharmaceuticals LLP is a limited liability partnership (LLP) based in Savli, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 October 2014 and has been in existence for over 12 years.
The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAC-7995. Its GSTIN is 24AAOFB3327K1ZE (Gujarat).
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Nandkishore Maheshwari and Vedant Nandkishore Maheshwari.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at At & Po. Manjusar Nr Guru Krupa Farm Manjusar, Savli, Gujarat, India – 391775.
As per the financials filed for FY 2024, the LLP reported a revenue of ₹33.75 Cr. For the same year it recorded a net profit of ₹93.57 Lakh (net margin 2.8%) and EBITDA of ₹1.51 Cr (EBITDA margin 4.5%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 7% over five years.
The LLP has about 194 employees on its provident fund (EPFO) records.
As per MCA filings, the LLP has open charges of ₹13.6 Cr and satisfied charges of ₹4.99 Cr on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressAt & Po. Manjusar Nr Guru Krupa Farm Manjusar, Savli, Gujarat, India – 391775
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Mypher Pharmaceuticals LLP FY 2025 filings available
Mypher Pharmaceuticals LLP reported revenue of ₹33.75 Cr for FY 2024.
Compounded Annual Growth Rate (CAGR) of Mypher Pharmaceuticals LLP
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years. EBITDA rose 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Mypher Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | ₹33.75 Cr | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | ₹93.57 Lakh | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Mypher Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 2.8% | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Mypher Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Mypher Pharmaceuticals LLP
Mypher Pharmaceuticals has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nandkishore Maheshwari | Designated Partner | 10 Oct 2014 | 11 Years 11 Months | Current |
| Vedant Nandkishore Maheshwari | Designated Partner | 10 Oct 2014 | 11 Years 11 Months | Current |
Ownership and Shareholding of Mypher Pharmaceuticals LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Mypher Pharmaceuticals LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jun 2024 | Axis Bank Limited | ₹4.38 Cr | Open |
| 29 Jul 2020 | State Bank of India | ₹4.61 Cr | Open |
| 07 Dec 2019 | State Bank of India | ₹4.61 Cr | Open |
| 14 Dec 2015 | Indusind Bank Ltd | ₹2 Cr | Satisfied |
| 27 Nov 2015 | Indusind Bank Ltd | ₹2 Cr | Satisfied |
Total charge records: 6 View all charges
Employees and EPFO Compliance at Mypher Pharmaceuticals LLP
Mypher Pharmaceuticals LLP has a workforce of 194 employees as of Feb 28, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Mypher Pharmaceuticals LLP
Mypher Pharmaceuticals LLP has 2 designated partner changes on record since 2014: 2 appointments. The latest: Nandkishore Maheshwari was appointed as Designated Partner on 10 Oct 2014.
5 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Mypher Pharmaceuticals LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Mypher Pharmaceuticals LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mypher Pharmaceuticals LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Mypher Pharmaceuticals LLP
Mypher Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAOFB3327K1ZE | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mypher Pharmaceuticals LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mypher Pharmaceuticals LLP
Mypher Pharmaceuticals is an active limited liability partnership based in Savli, Gujarat, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 10 October 2014 (12+ years old) and is registered under LLPIN AAC-7995.
Mypher Pharmaceuticals reported revenue of ₹33.75 Cr for FY 2024.
Mypher Pharmaceuticals has 2 current designated partners:
- Nandkishore Maheshwari - Designated Partner
- Vedant Nandkishore Maheshwari - Designated Partner
Mypher Pharmaceuticals reported a net profit of ₹93.57 Lakh (net margin 2.8%) and EBITDA of ₹1.51 Cr (EBITDA margin 4.5%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Mypher Pharmaceuticals is 10% over three years and 7% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Mypher Pharmaceuticals is 24AAOFB3327K1ZE, registered in Gujarat.
The LLPIN (Limited Liability Partnership Identification Number) of Mypher Pharmaceuticals is AAC-7995. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Mypher Pharmaceuticals was incorporated on 10 October 2014, making it 12+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Nandkishore Maheshwari was appointed as Designated Partner on 10 Oct 2014. Vedant Nandkishore Maheshwari was appointed as Designated Partner on 10 Oct 2014.
The registered office of Mypher Pharmaceuticals is at At & Po. Manjusar Nr Guru Krupa Farm Manjusar, Savli, Gujarat, India – 391775.